20-10644907-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP6BS1BS2
The NM_000214.3(JAG1):c.2300C>T(p.Thr767Met) variant causes a missense change. The variant allele was found at a frequency of 0.000123 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T767R) has been classified as Uncertain significance.
Frequency
Consequence
NM_000214.3 missense
Scores
Clinical Significance
Conservation
Publications
- Alagille syndrome due to a JAG1 point mutationInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
 - Charcot-Marie-Tooth disease, axonal, Type 2HHInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
 - tetralogy of fallotInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| JAG1 | ENST00000254958.10  | c.2300C>T | p.Thr767Met | missense_variant | Exon 18 of 26 | 1 | NM_000214.3 | ENSP00000254958.4 | ||
| JAG1 | ENST00000423891.6  | n.2166C>T | non_coding_transcript_exon_variant | Exon 16 of 25 | 2 | |||||
| JAG1 | ENST00000488480.2  | n.697C>T | non_coding_transcript_exon_variant | Exon 4 of 4 | 4 | |||||
| JAG1 | ENST00000617965.2  | n.2889C>T | non_coding_transcript_exon_variant | Exon 12 of 17 | 5 | 
Frequencies
GnomAD3 genomes   AF:  0.0000657  AC: 10AN: 152118Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.0000596  AC: 15AN: 251484 AF XY:  0.0000515   show subpopulations 
GnomAD4 exome  AF:  0.000129  AC: 188AN: 1461840Hom.:  0  Cov.: 31 AF XY:  0.000132  AC XY: 96AN XY: 727224 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000657  AC: 10AN: 152118Hom.:  0  Cov.: 33 AF XY:  0.0000269  AC XY: 2AN XY: 74306 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Isolated Nonsyndromic Congenital Heart Disease    Uncertain:1 
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not provided    Uncertain:1 
- -
Cardiovascular phenotype    Uncertain:1 
The p.T767M variant (also known as c.2300C>T), located in coding exon 18 of the JAG1 gene, results from a C to T substitution at nucleotide position 2300. The threonine at codon 767 is replaced by methionine, an amino acid with similar properties. This alteration was detected in one family in a study of suspected Alagille syndrome cases; however, the diagnosis of Alagille syndrome was unlikely after further clinical assessment, and clinical details were limited (Guegan K et al. Clin. Genet., 2012 Jul;82:33-40). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Alagille syndrome due to a JAG1 point mutation    Benign:1 
- -
Tetralogy of Fallot;C1866053:Deafness, congenital heart defects, and posterior embryotoxon;C1956125:Alagille syndrome due to a JAG1 point mutation;C5562003:Charcot-Marie-Tooth disease, axonal, Type 2HH    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at